Cargando…
251 A Mixed Methods Study of Patient and Clinician Views and Experiences of Pharmacogenomic Testing for Major Depressive Disorder
OBJECTIVES/GOALS: Pharmacogenomic testing for major depressive disorder is an expanding area of precision medicine with multiple direct-to-provider tests available. While clinical evidence supporting testing is expanding, there has been little research on the views and experiences of patients and cl...
Autores principales: | Hendy, Katherine, Ellingrod, Vicki, Roberts, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129575/ http://dx.doi.org/10.1017/cts.2023.318 |
Ejemplares similares
-
54443 Pharmacogenomic Profiling of East and West African Populations
por: Jackson, Linsey, et al.
Publicado: (2021) -
349 Translation of novel multidisciplinary health technologies in the Ontario healthcare system: A case study of pharmacogenomic testing
por: Neumark, Samuel, et al.
Publicado: (2023) -
48352 Mechanisms Underlying Lipidomic Changes in Major Depressive Disorder
por: Costa, Ana Paula, et al.
Publicado: (2021) -
360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens
por: Mojica, Wilfrido, et al.
Publicado: (2023) -
4292 Epigenetic Age and Depressive Symptoms in African American Women with Cardiometabolic Conditions
por: Perez, Nicole B, et al.
Publicado: (2020)